Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

ABOUT US

Sichuan Yuanda Shuyang Pharmaceutical is a professional supplier of Human Immunoglobulin for Intravenous Injection PH4,Human hepatitis B immunoglobulin IV.,Human Hepatitis B Immunoglobulin IM.,Human Rabies Immunoglobulin.,Human tetanus immunoglobulin. we have the following strength:

1.Shuyang was accepted and obtained certification for the newest edition of the national GMP as well as the Russian and Turkish Ministries of Health.

2.Shuyang was the first to pass integrated certification for ISO9001,ISO14001,OHSAS18001 in the Chinese Plasma Product industry

3.Shuyang`s plasma pool and finished products were passed the test performed by Paul-Ehrlich-Institute in compliance with European Pharmacopeia.

4.The preparation process of dual inactivation of virus without protective has received patents in the United States of America, Australia and China.

5.Among the top three enterprises in terms of comprehensive strength in the Chinese plasma product industry

6.Part of the first group of national high-tech enterprise in Sichuan Province

7.Honored as the enterprises with [unblemished quality" record by the state

8.No.1 export sales of plasma product in China.

VIEW MORE VISIT OUR FACTORY
OUR PRODUCTMORE >>

HOT PRODUCTS

FACTORY

COMPANY CERTIFICATE

LATEST NEWS

Summer Benefits in Grand Life Sciences

Recently, Shenyang has continued to experience high temperatures. On August 23rd, one of the twenty-four solar terms in China - the limit of heat, the high temperature in the afternoon made the employees feel tired and sleepy. In order to give coolness to the hard-working employees in various positions, the Human Resources Department of Grand Life Sciences (Liaoning) Co., Ltd. set up a "Summer Dessert Station" at the reception lobby of the office building to deliver drinks and desserts to everyone, attracting more than 200 employees from the factory. In addition, August 22 this year is Chinese Valentine's Day. In Penglai Nuokang Pharmaceutical Co. Ltd., the company leaders decided to make yogurt cups to present this gift of love to employees who are busy with production and administrative services. At 10:00 in the morning, the leaders and managers of the company started the intensive production of yogurt cups, cutting fruit, packing yogurt, boxing, decoration, delivery, etc. Everyone worked together, and soon completed the production and distribution of those loving yogurt cups. The purpose of this activity is to carry forward Chinese traditional culture, convey the sense of happiness of the Nuokang family, and promote the healthy growth of modern family concepts. As a well-known pharmaceutical manufacturer in China, Grand Life Sciences (Liaoning) Co., Ltd. aims to provide high-quality and competitive pharmaceuticals to people around the world, including hemostatic products, analgesic products, anesthesia products, nutritional supplements, etc.

04 September-2023

Shuyang Won the Title of 2022 Chengdu Industrial Tourism Demonstration Site

Recently, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (hereinafter referred to as "Shuyang") won the title of 2022 Chengdu Industrial Tourism Demonstration Site. Yuanda Shuyang is the first industrial tourism base of Chengdu pharmaceutical companies, and has become a new landmark of Chengdu industrial tourism. After visiting Shuyang's "Tree of Life" art exhibition, "Journey of Life" enterprise exhibition hall, and blood product production line, the leader of the preparatory group of Sichuan Industrial Culture Development Association Cai Jing highly affirmed Shuyang's exploration and future development planning in industrial tourism and cultural construction. He said that the rise of the biopharmaceutical industry is of great significance to improving people's quality of life. As a subdivision of biopharmaceuticals, the blood product industry plays an important clinical role in the fields of intensive care, rare diseases, and immune system diseases. It is hoped that Shuyang will continue to invest in R&D and innovation to promote the development of high-end manufacturing industries. The manufacturing base of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. is located at No. 888, 5th Antai Road, High-tech Zone, Chengdu. The base has a total investment of more than 2 billion RMB and complies with China GMP and EU GMP standards. It can simultaneously produce blood products for three major categories of plasma sources: human albumin, immunoglobulin, and coagulation factors. Yuanda Shuyang Pharmaceutical Co., Ltd. will combine biomedical health culture and citizens' leisure and tourism needs to further enrich tourism content, and at the same adhere to the core of R&D and innovation, and contribute our strength to the progress of human health.

10 August-2023

7.16 Walking Activity of Grand Life Science (Liaoning) Co., Ltd.

On July 16, the walking activity of Grand Life Science (Liaoning) Co., Ltd. was held in Mozishan Park, Shenyang. Huang Ling, chairman of the company, Liu Liping, deputy general manager and CFO, Dong Jing, general manager of Penglai Nuokang, Zhang Lei, general manager of Liaoning Weibang, and other leaders attended the event. Although it rained during this activity, it did not affect everyone's enthusiasm at all. With the sound of the command, all participants set off from the starting point. Everyone's laughter blended with the scenery along the way. The track is 7.16 km long, and 3 group games are interspersed in the middle, which not only tests everyone's physical strength and perseverance, but also tests the communication and cooperation skills. These projects fully embody the team spirit of unity, fearlessness and close cooperation. After reaching the finish line, everyone went to the finishing area to take group photos together to record this exciting and unforgettable moment. At the awards ceremony, Chairman Huang Ling and other leaders presented prizes to the champion team and other outstanding teams, affirming and encouraging everyone's performance in the activity. Although the walking activity is over, the struggle of Grand Life Sciences will never stop. The successful holding of this activity has enhanced team cohesion and combat effectiveness. We believe that everyone will contribute to the development of the company with fuller enthusiasm and positive attitude. Grand Life Sciences (Liaoning) Co., Ltd. is a major member of China Grand Enterprises, providing perioperative high-end preparations and medical devices made of biodegradable materials. The company has an innovative drug R&D center, a high-tech barrier emulsion R&D center, and an enzymatic engineering transformation platform, and is supported by a modern production base, an API base, and a Peruvian snake venom supply base. Now we are concentrating on the chemical medicine export business, aims to provide high-quality and competitive pharmaceuticals to people around the world, including hemostatic products, analgesic products, anesthesia products, nutritional supplements, etc. please contact us if you are interested.

28 July-2023

Shuyang Human Immunoglobulin-Neural Expert Academic Conference

From July 7 to 9, 2023, the first Shuyang Human Immunoglobulin-Neural Expert Academic Conference "2023 Human Immunoglobulin Neuroimmune Expert Advisory Meeting" was successfully held in Chengdu. With the purpose of exploring the future research direction of human immunoglobulin and promoting the rational and standardized drug use in clinical practice, the meeting carried out wonderful academic content sharing and panel discussions. During the meeting, the experts jointly discussed the differences in the application of human immunoglobulin between China and foreign countries, and offered suggestions for the academic promotion of human immunoglobulin. At the beginning of the conference, Professor Dong Huiqing, the chairman of the conference, and Feng Zenghui, chairman of Grand Life Sciences Group, delivered speeches respectively. Professor Dong welcomed all the guests attending the conference, and thanked Shuyang for the academic platform, and hoped to have more cooperation with Shuyang in the future. Chairman Feng introduced the company's development history and future development plan, and at the same time expressed Shuyang's willingness to continue exploring in the field of neuroimmunology. Then Fu Zhengming, deputy general manager of Shuyang Marketing Center, introduced the company, focusing on the history of Shuyang, the establishment of the new factory and the advantages of human immunoglobulin. In the topic sharing session, Professor Lu Zuneng from People's Hospital of Wuhan University shared the first topic "Overview of the Application of IVIG in Neuroimmune Diseases", focusing on the application value of human immunoglobulin in the entire neuroimmune field. In the second topic, Professor Huang Tianwen from Fujian Medical University Union Hospital shared "Current Status of Diagnosis and Treatment of CIDP and Exploration of IVIG Opportunities", focusing on the current status of diagnosis and treatment of CIDP, the evidence-based basis and existing research of human immunoglobulin in CIDP. Through this expert advisory meeting, Shuyang Company completed the national-level expert network construction in the field of neuroimmunology, which opened a good start for further deepening the field of neurology. The meeting preliminarily clarified the current and future pattern of human immunoglobulin in neuroimmunology, and provided ideas for Shuyang product layout.

21 July-2023

Grand Life Sciences Group Co., Ltd.

Grand Life Sciences Group Co., Ltd. (hereinafter referred to as "GLS ") is a modern pharmaceutical enterprise group, which integrates R&D, production and sales, and focuses on immunity, infection, severe disease, blood system, digestion and wound management, etc. The group has R&D centers and production bases in more than ten cities including Beijing, Chengdu, Hangzhou, Shenyang, Wuhan, Chongqing, Nanjing, Zhengzhou, Yantai, Anshan, etc., and is committed to the research and development of high-end blood products, chemical drugs, new recombinant vaccines, nano-targeted preparations, degradable medical devices and high-value raw materials. In the field of blood products, GLS owns Yuanda Shuyang Pharmaceutical Co., Ltd, one of the top 20 biopharmaceutical companies in China, and the production capacity of its newly built modern factory ranks first in Asia and among the top 10 in the world. The factory not only complies with Chinese GMP standards, but also meets EU and WHO standards. Shuyang products have covered the domestic market and exported to more than 10 countries. In 2021, with the approval of the National Medical Products Administration (NMPA) for the human fibrinogen product, Yuanda Shuyang Pharmaceutical has taken an important step in the field of blood coagulation factors. In the future, it will focus on the development of the full product line of blood products and continue to dig deeper in rare diseases. In the field of chemical medicine, GLS relies on the four major industrial bases of Grand Life Sciences (Liaoning), Grand Life Sciences (Wuhan), Penglai Nuokang and Liaoning Weibang. The company gives full play to the advantages of large industrial foundation and the raw materials-preparations integration to create nano-target R&D center, enzymatic engineering and polymer material R&D platform, API base and Peruvian snake venom supply base, and is committed to providing original biological drugs, emulsions, high-end preparation products and biodegradable medical devices. Focus on developing perioperative product groups, including hemostasis, anesthesia, analgesia, and anticoagulant drugs. Among them, Hemocoagulase Bothrops Atrox for Injection is the product with the largest share in the domestic hemostatic market, Flurbiprofen Axetil is the first domestically-made targeted analgesic injection, and Collagenase Ointment is currently the only enzymatic debridement drug officially approved at home and abroad. As a well-known pharmaceutical manufacturer in China, Grand Life Sciences (Liaoning) Co., Ltd. aims to provide high-quality and competitive pharmaceuticals to people around the world, including hemostatic products, analgesic products, anesthesia products, nutritional supplements, etc.

14 July-2023

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send